Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2869
Selected: 0
NCT IDTitle
NCT01335399Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma
NCT00825955Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment
NCT06549608A Retrospective Cohort Study of Mavacamten Patient Support Program in Canada
NCT00123487Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML
NCT05901714A Study to Assess the Effect of Phenytoin on the Drug Levels of Afimetoran and the Effect of Afimetoran on the Drug Levels of Midazolam
NCT00972933Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma
NCT01361555Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
NCT05200143Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma
NCT02792335Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients
NCT05665192A Study to Assess Real-World Patient-Reported Outcomes With Fedratinib for Myelofibrosis Post-Ruxolitinib
NCT02224768YERVOY® Risk Minimization Tool Effectiveness Evaluation Survey
NCT00035152Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer
NCT03316274Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma
NCT02857426A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL)
NCT00277225A Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis Vulgaris
NCT03425825Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC)
NCT02161406A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
NCT00683878Add-on to Thiazolidinedione (TZD) Failures
NCT05236608A Study to Evaluate the Combination of Nivolumab With ADG106 in Metastatic NSCLC
NCT06107738Iberdomide and Daratumumab As Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
NCT05162443Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation
NCT02546791Frequency and Severity of Pleural Effusion Associated With the Use of Dasatinib in Patients With Chronic Myeloid Leukemia. A Descriptive, Mexican Multicenter Study
NCT00729664Multiple Ascending Dose (MDX1105-01)
NCT06298643Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan
NCT02423343A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma
NCT00036608A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine
NCT00381706Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
NCT06568458A Study to Assess the Extent of Drug Interaction Between BMS-986278 and Nintedanib, the Relative Bioavailability of BMS-986278 in Tablet and the Effect That Food Has on BMS-986278 in Tablet Formulations in Healthy Participants
NCT00412984Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
NCT02107755Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma
NCT01167244Trial of BMS-690514 in Non-Small Cell Lung Cancer Subjects Who Have Been Treated With Gefitinib or Erlotinib and Are Genotypically EGFR Mutation Positive or Who Have Had a Prior Response
NCT03254784A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation
NCT07223671Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants
NCT00773344Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin
NCT06951698A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
NCT00688493Effects of Single Oral Dose Dapagliflozin QT Study
NCT00246987A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control
NCT03362437Evaluate the Pharmacokinetics of BMS-986177 From Two Formulations in Healthy Participants
NCT02115139GEM STUDY: Radiation And Yervoy in Patients With Melanoma and Brain Metastases
NCT03841201Immunotherapy With Nivolumab in Combination With Lenvatinib for Advanced Stage Hepatocellular Carcinoma
NCT01755494A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-Administration
NCT01082562Safety Study of BMS-844421 for Treatment of Hypercholesterolemia
NCT03333746Lenalidomide and Nivolumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT02593786A Study of Safety, Tolerability and Pharmacokinetics of Nivolumab in Chinese Subjects With Previously Treated Advanced or Recurrent Solid Tumors
NCT00046345Atazanavir for HIV Infected Individuals: An Early Access Program
NCT03634969An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants
NCT03515083Better Outcomes for Anticoagulation Treatment Through Observation of Atrial Rhythm
NCT02297139Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib
NCT00007657Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation
NCT02389972Effectiveness of Dasatinib in Adult Patients With Chronic Myeloid Leukemia in China: A Multicenter, Registry Study